Rite Aid

Rite Aid Corp. engages in the ownership and management of retail drug stores. It operates through following segments: Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment includes branded and generic prescription drugs, health and beauty aids, personal care products, and walk-in retail clinics. The Pharmacy Services segment offers transparent and traditional pharmacy benefit management for insurance companies, employers, health plans, and government employee groups. The company was founded by Alex Grass on September 12, 1962 and is headquartered in Philadelphia, PA.

Earnings data Q2 2023

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Rite Aid Corp. engages in the ownership and management of retail drug stores. It operates through the Retail Pharmacy and Pharmacy Services segments. The Retail Pharmacy segment includes branded and generic prescription drugs, health and beauty aids, personal care products, and walk-in retail clinics. The Pharmacy Services segment offers transparent and traditional pharmacy benefit management for insurance companies, employers, health plans, and government employee groups. The company was founded by Alex Grass on September 12, 1962 and is headquartered in Philadelphia, PA.

Rite Aid is a health products and services company with 2,400 locations across 17 states.

The company's omnichannel business includes digital, retail, and delivery touchpoints. Rite Aid is a top 20 seller of speciality medications, per its investor website.

In addition to its retail business, Rite Aid owns a pharmacy benefits subdivision (Elixir) and a personalized health services and coaching arm, Health Dialog, which has served 10MM members as of May 2022.

The company has reported $1.85 billion of liquidity with no debt maturities until 2025. According to its investor website, Rite Aid expects to be free cash flow (FCF) positive in FY23.

In Q2 2022, Rite Aid shared a three-part growth strategy aimed at deepening market share, expanding into new markets, and creating new offerings.

To grow the current business, Rite Aid is aiming to increase its e-commerce and digital sales, refresh its loyalty program, and grow its specialty pharmacy offering, which focuses on serving customers with complex health conditions.

New market expansion plans include increasing Rite Aid's footprint of "small format" pharmacies in underserved communities and implementing "store within a store" partnerships.

Rite Aid also aims to grow via new offerings, such as expanded health plan and health system clinical services, a pharmacy benefit manager (PBM) as a service offering, and new strategic partnerships.

Rite Aid Investor Relations

*This is not investment advice.

Rite Aid Corp. RAD, +2.90% shares rose 2.4% in Tuesday premarket trading after the pharmacy retailer reported a surprise third-quarter adjusted profit and announced dozens of store closures. Net loss totaled $36.1 million, or 67 cents per share, after net income of $4.3 million, or 8 cents per share, last year.

Rite Aid stock jumps after surprise adjusted profit, store closures announced

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid Corporation (NYSE: RAD) today reported operating results for its third fiscal quarter ended November 27, 2021. For the third quarter, the company reported net loss from continuing operations of $36.1 million, or $0.67 loss per share, Adjusted net income from continuing operations of $8.2 million, or $0.15 income per share, and Adjusted EBITDA from continuing operations of $154.8 million, or 2.5 percent of revenues. “We delivered a solid quarter as we gr

Rite Aid Corporation Reports Fiscal 2022 Third Quarter Results

BlackBerry

General Mills

CarMax

Paychex

The shortened holiday week will see less public offerings and earnings from public companies. The week can still bring plenty of trading opportunities with headlines and catalysts.

5 Companies That Could Beat Earnings Estimates This Week: Rite Aid, BlackBerry And More

The shares of drugstore chain Rite Aid Corporation (NYSE:RAD) are down 2.2% to trade at $11.80 this afternoon, just ahead of the company's third-quarter earnings report -- due out before the open tomorrow.

Struggling Rite Aid Stock Lower Before Earnings

Micron Technology

NIKE

Four companies we have previewed reported quarterly results after markets closed Thursday or before they opened on Friday.

Earnings Preview: General Mills, Micron, Nike, Rite Aid

Rite Aid (RAD) is likely to have gained from strength in PBM, RxEvolution strategy and delivery services in Q3. Rising wage costs and drab front-end same-store sales are likely to have been concerns.

Factors Likely to Influence Rite Aid (RAD) in Q3 Earnings

Rite Aid (RAD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Rite Aid (RAD) to Report a Decline in Earnings: What to Look Out for

AutoZone

Best Buy

CVS Health

Home Depot

Kroger

Target

Walgreens

The chief executives of major U.S. retailers including Target, Home Depot, Kroger, CVS Health, Autozone and Best Buy on Thursday urged Congress to take action to address some anonymous online sales, citing the growing impact of organized retail crime.

Major U.S. retailers urge action by Congress on online sellers

Investors need to pay close attention to Rite Aid (RAD) stock based on the movements in the options market lately.

Is the Options Market Predicting a Spike in Rite Aid (RAD) Stock?

Strength in online services and the PBM market will likely aid Rite Aid (RAD) in the times ahead. However, higher costs related to the Bartell acquisition and COVID-19 vaccines remain concerning.

Rite Aid (RAD) Stock Dips 13% YTD: Can It Get Back on Track?

The Zacks Retail Pharmacy and Drugstore industry is gaining from the growing demand for digital healthcare support. Industry players like CVS and RAD are likely to gain the most.

2 Retail Pharmacy and Drugstore Stocks to Watch Amid Industry Headwinds

PHILADELPHIA--(BUSINESS WIRE)--On November 2, 2021, the Centers for Disease Control and Prevention (CDC) concurred with previous recommendations made by the Food and Drug Administration (FDA) and the Advisory Committee on Immunization Practices (ACIP), officially authorizing the emergency use of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 to include children 5 through 11 years of age. The Pfizer-BioNTech COVID-19 Vaccine for children 5 through 11 years of age is administ

Rite Aid Statement on CDC Recommendation Regarding COVID-19 Vaccine for Children Ages 5-11

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid Corporation (NYSE: RAD) announced today that Heyward Donigan, president and chief executive officer; Jim Peters, chief operating officer and Matt Schroeder, executive vice president and chief financial officer will participate in a fireside chat with investors at the 30th Annual Credit Suisse Healthcare Conference on Wednesday, Nov. 10th at approximately 9:40 a.m. ET. The conference is a virtual event. The appearance will be broadcast via the Internet a

Rite Aid to Present at the 30th Annual Credit Suisse Healthcare Conference

Uber

Customers can now get health items from Rite Aid through Uber Eats, though not prescriptions.

Rite Aid joins with Uber Eats to expand on-demand delivery

PHILADELPHIA--(BUSINESS WIRE)--Today the Centers for Disease Control and Prevention (CDC) concurred with previous recommendations made by the Food and Drug Administration (FDA) and the Advisory Committee on Immunization Practices (ACIP), officially recommending “booster” doses of the Pfizer-BioNTech COVID-19 vaccine for certain eligible populations at least 6 months after the second dose of the Pfizer-BioNTech COVID-19 vaccine. As a proud partner in the Federal Retail Pharmacy Program, Rite Aid

Rite Aid Statement on CDC Recommendation Regarding COVID-19 Vaccine “Boosters”

Rite Aid on Friday (Sept. 24) broadened its partnership with Uber Technologies, Inc., and is now offering delivery of healthcare items, groceries and Rite Aid products through the Uber Eats platform from 2,185 Rite Aid locations across the U.S. in 17 states.

Rite Aid On-Demand Delivery Goes National with Uber Eats

SEATTLE, Sept. 24, 2021 /PRNewswire/ -- Today, Bartell Drugs (Bartell's) announced a new partnership with Uber Technologies, Inc. (NYSE: UBER) to offer delivery of Bartell's products in the Puget Sound region through Uber Eats.

Bartell Drugs Announces Partnership With Uber To Expand On-demand Delivery Throughout Western Washington

Despite high costs, Rite Aid's (RAD) fiscal second-quarter results have been aided by increased demand as well as strength in Elixir and the Retail Pharmacy unit.

Rite Aid (RAD) Q2 Loss Narrower Than Expected, Revenues Miss

PHILADELPHIA--(BUSINESS WIRE)--Today, Rite Aid (NYSE: RAD) announced the expansion of their partnership with Uber Technologies, Inc. (NYSE: UBER) to offer delivery of Rite Aid products nationwide through Uber Eats. This partnership will allow customers to conveniently order and receive essential healthcare and grocery items directly to their homes. On-demand delivery is now available for 2,185 Rite Aid locations across 17 states on Uber Eats. Customers who wish to order Rite Aid items for deliv

Rite Aid Partners With Uber Eats to Expand On-Demand Delivery Nationwide

Rite Aid Corporation (RAD) CEO Heyward Donigan on Q2 2022 Results - Earnings Call Transcript

Investors reacted negatively to the company's Q2 update.

Why Rite Aid Stock Is Sinking Today

Rite Aid is pointing to pharmaceuticals and its pharmacists as the key to growing and transforming its business, though bigger competitors whose strategies are more developed may put some speed bumps along that road. CEO Heyward Donigan, who just celebrated two years with the company, told analysts and investors on a conference call that Rite […]

Rite Aid Touts Importance of Pharmacists in Business Growth

Rite Aid Corporation (NYSE: RAD) has reported Q2 FY22 adjusted net loss of ($0.41) per share, compared to an income of $0.25 a year ago, but beating the consensus of $(0.48). Earnings: Revenues increased 2.2% Y/Y to $6.11 billion, missing the estimate of $6.21 billion.

Rite Aid Shares Crumble After Expecting Wider Annual Net Loss For Fiscal 2022

Rite Aid (RAD) delivered earnings and revenue surprises of 2.38% and -2.13%, respectively, for the quarter ended August 2021. Do the numbers hold clues to what lies ahead for the stock?

Rite Aid (RAD) Reports Q2 Loss, Misses Revenue Estimates

Shares of Rite Aid Corp. RAD, +1.06% edged up 0.7% in premarket trading Thursday, after the drugstore chain reported a narrower-than-expected fiscal second-quarter loss, citing "strong execution" of COVID-19 vaccine administration, even as revenue came up short and the full-year loss outlook was widened. The net loss for the quarter to Aug. 28 widened to $100.3 million, or $1.86 a share, from $13.2 million, or 25 cents a share, in the year-ago period, citing higher litigation settlements, higher loss on sale of assets and a loss on debt modifications.

News for Rite Aid Stock (RAD)